19-51341963-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001163922.3(VSIG10L):āc.85C>Gā(p.Gln29Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000786 in 1,399,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001163922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG10L | NM_001163922.3 | c.85C>G | p.Gln29Glu | missense_variant | 2/10 | ENST00000335624.5 | NP_001157394.1 | |
VSIG10L-AS1 | NR_186316.1 | n.921G>C | non_coding_transcript_exon_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG10L | ENST00000335624.5 | c.85C>G | p.Gln29Glu | missense_variant | 2/10 | 5 | NM_001163922.3 | ENSP00000335623.3 | ||
VSIG10L-AS1 | ENST00000594311.1 | n.224G>C | non_coding_transcript_exon_variant | 3/4 | 5 | |||||
VSIG10L-AS1 | ENST00000601148.5 | n.246G>C | non_coding_transcript_exon_variant | 3/5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000195 AC: 3AN: 154128Hom.: 0 AF XY: 0.0000367 AC XY: 3AN XY: 81752
GnomAD4 exome AF: 0.00000786 AC: 11AN: 1399422Hom.: 0 Cov.: 78 AF XY: 0.0000130 AC XY: 9AN XY: 690214
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | The c.85C>G (p.Q29E) alteration is located in exon 2 (coding exon 2) of the VSIG10L gene. This alteration results from a C to G substitution at nucleotide position 85, causing the glutamine (Q) at amino acid position 29 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at